Atlas FDA

EXABLATE

FDA premarket approval P110039/S003 · decided 2013-08-06

Approval details

PMA number
P110039
Supplement
S003
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol - OSB
Trade name
EXABLATE
Generic name
Ablation system, high intensity focused ultrasound (HIFU), MR-guided
Applicant
Insightec
Date received
2013-06-28
Decision date
2013-08-06
Days to decision
39 days
Decision code
APPR
Product code
NRZ
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Tirat Carmel
Statement
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.